Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06038123
Other study ID # MDT23009
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 28, 2023
Est. completion date July 31, 2024

Study information

Verified date September 2023
Source Medtronic Cardiac Rhythm and Heart Failure
Contact Peter Tang, Master
Phone +86 15921265787
Email peter.tang@medtronic.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the China CIED 3.0T MRI Performance Study is to confirm safety of SureScan CIED in the clinical 3.0T MRI environment when subjects receive MRI scans. ll subjects will have required follow-up visits at baseline, MRI visit, 1-month post-MRI. The MRI scans will occur at the MRI visit. The MRI scan region will be determined by investigator according to the subject's clinical condition.


Recruitment information / eligibility

Status Recruiting
Enrollment 64
Est. completion date July 31, 2024
Est. primary completion date July 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Subjects who were implanted an SureScan system CIED over 6 weeks at the time of signing ICF. - Subjects who are able and willing to undergo elective MRI scanning without sedation. - Subjects who were implanted an SureScan system CIED in the pectoral region. - Subjects who are geographically stable and available for follow-up at the study site for the length of the study. - Subjects who are at least 18 years of age (or older, if required by local law). Exclusion Criteria: - Subjects who require a legally authorized representative to obtain informed consent. - Subjects with abandoned or capped leads. - Subjects who require an indicated MRI scan, other than those specifically described in the China CIED 3.0T MRI performance study, before the 1-month post-MRI follow-up. - Subjects with a non-MRI compatible device (such as neurostimulators) or material implant (e.g., non-MRI compatible sternal wires, neurostimulators, biostimulators, metals or alloys). - Subjects with medical conditions that preclude the testing required by the CIP or limit study participation. - Subjects who are enrolled or intend to participate in another clinical trial (of an investigational drug or device, new indication for an approved drug or device, or requirement of additional testing beyond standard clinical practice) during the SureScan study. Co-enrollment in concurrent trials is only allowed when documented pre-approval is obtained from the Medtronic study manager. - Female patient who is pregnant, or of childbearing potential and not on a reliable form of birth control. Women of childbearing potential are required to have a negative pregnancy test within seven (7) days prior to device implant.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
China market released 3.0T Magnetic resonance (MR) conditional CIED systems
To confirm safety and effectiveness of the SureScan CIED System in the clinical MRI environment when subjects receive 3.0T MRI scans without positioning restrictions (MRI scans may occur anywhere on the body)

Locations

Country Name City State
China Shanxi Cardiovascular Hospital Taiyuan Shanxi
China The First Affiliated Hospital of Xinjiang Medical University Urumqi Xinjiang

Sponsors (1)

Lead Sponsor Collaborator
Medtronic Cardiac Rhythm and Heart Failure

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The occurrence of an MRI-related event for CIED The occurrence of any of the following within 30 days after the 3.0T MRI visit will be considered an MRI-related event for CIED:
Medical advisor-assessed MRI-related complication within 30 days post-MRI
Medical advisor-assessed right ventricular MRI-related loss of capture within 30 days post-MRI
Sustained tachyarrhythmia originating during SureScan programming, requiring immediate treatment (defined as ATP, device shock, or external shock) as assessed by a medical advisor.
The event will be collected within 30 days after MRI visit.
Secondary The changes in atrial and ventricular pacing capture thresholds of APCT from pre-MRI to 1-month post-MRI scan. PCTs to be evaluated include:
Atrial pacing capture threshold (if applicable)
The evaluation will be compared from pre-MRI to 1-month post-MRI scan
Secondary The changes in atrial and ventricular pacing capture thresholds of VPCT from pre-MRI to 1-month post-MRI scan. PCTs to be evaluated include:
Ventricular pacing capture threshold (both right and left ventricular lead if applicable)
The evaluation will be compared from pre-MRI to 1-month post-MRI scan
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy